United States Infection Control Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Product (Disinfectants, Sterilization (Low-Temperature Sterilization, Heat Sterilization, Contract Sterilization)), By End User Industry (Healthcare, Food And Beverage, Chemical) - Forecasts From 2022 To 2027

The United States infection control market is evaluated at US$6,990.89 million for the year 2020 and is projected to grow at a CAGR of 11.68% to reach a market size of US$15,145.71 million by the year 2027.

There has been an increase in the number of individuals in the population undergoing surgical procedures as a result of the rise in infections that are being contracted in hospitals (hospital-acquired infections). This is leading to a surge in demand for infection control solutions and practices by doctors and healthcare professionals and is resulting in bolstering the market growth over the forecast period. In addition, the rise in consumption of harmful substances such as alcohol and tobacco has led to an increase in cases of serious diseases such as cancer, diabetes, emphysema, and tuberculosis, increasing the demand for hospital services, which is boosting the growth of the market.  

Moreover, there is the active involvement of the government in the form of high-degree infection prevention and public healthcare advice and steps being taken to minimize the spread of serious infections and widespread infection prevention. For example, the guidelines laid down by the World Health Organization (WHO) for the effective prevention and control of epidemics and pandemics related to diseases in healthcare facilities and institutions provide the recommendation concerning the practices of adequate hygiene, usage of personal protective equipment, and strict guidelines regarding sanitization, sterilization, and disinfection.

Furthermore, the market players are increasingly participating and involved in the market through product offerings and product launches in order to cater to the rising demand among the end-users effectively. For instance, ASP, one of the leading companies dealing in infection prevention products, offers sterilization and disinfection products under its product portfolio. The sterilization product is called the “STERRAD Systems,” It can lower the Hydrogen Peroxide emissions from the devices, thus protecting the instruments, users, patients, and environments in the hospitals. It has additional features, such as it does not produce toxic emissions and uses both plasma and hydrogen peroxide vapor for sterilization. The disinfection product is called the “EVOTECH ECR,” a consistent and reliable product that can facilitate the delivery of effective disinfection. It has some additional features, such as automatic leak detection and blockage detection.

Recent development and expansions

Strategies are being developed in the United States to develop infection control measures, improve the safety and quality of healthcare, and protect healthcare personnel and patients by strengthening Infection Prevention and Control (IPC). Improve the structure, design, and organisation of healthcare facilities. Improve the design of materials and equipment, as well as their safe use in healthcare settings. IPC work processes, procedures, and practices should be improved.

STERIS plc completed the acquisition of Cantel Medical on June 2, 2022, a global provider of infection prevention products and services to endoscopy, dental, dialysis, and life sciences customers.

Medtronic contributes to the reduction of infections associated with cardiac implants. Medtronic plc announced the release of the TYRX TYRX™ Absorbable Antibacterial Envelope (TYRX Envelope) on February 25, 2021 - and absorbable, single-use antibacterial envelope designed to stabilise a cardiac implanted neurostimulator, the implantable electronic device (CIED), or another medical device that releases antibiotics gradually over a minimum of seven days.

COVID-19 impact on United States Infection Control Market

The US government imposed nationwide social distancing rules that prohibited gatherings of more than ten people, avoided public places such as restaurants and bars, and avoided unnecessary travel. Social distancing rules were also imposed. The CDC created the (RT)-PCR diagnostic panel for testing COVID-19 patient specimens. The kit is used in conjunction with the Applied Biosystems 7500 Fast DX Real-Time PCR Instrument with SDS 1.4 software. The US Food and Drug Administration (FDA) approved it for emergency use under Emergency Use Authorization (EUA).
The CDC later announced that it would test coronavirus cases in five states, including Los Angeles, San Francisco, Seattle, Chicago, and New York, using its existing seasonal influenza surveillance system. Laboratories in these states are already tracking seasonal flu cases. Individuals who test negative for influenza are being tested for coronavirus.

United States Infection Control Market Scope:

Market Segmentation

• By Product
  • Disinfectant
  • Sterilization
    • Low-Temperature Sterilization
    • Heat Sterilization
    • Contact Sterilization
• By End-User Industry
  • Healthcare
  • Food and Beverage
  • Chemical